about
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.Current and emerging drugs for idiopathic pulmonary fibrosis.Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis.Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Emerging drugs for idiopathic pulmonary fibrosis.
@ast
Emerging drugs for idiopathic pulmonary fibrosis.
@en
type
label
Emerging drugs for idiopathic pulmonary fibrosis.
@ast
Emerging drugs for idiopathic pulmonary fibrosis.
@en
prefLabel
Emerging drugs for idiopathic pulmonary fibrosis.
@ast
Emerging drugs for idiopathic pulmonary fibrosis.
@en
P2093
P2860
P1476
Emerging drugs for idiopathic pulmonary fibrosis.
@en
P2093
Joseph P Lynch
Kevin R Flaherty
Robert C Hyzy
Victor J Thannickal
P2860
P304
P356
10.1517/14728214.10.4.707
P407
P577
2005-11-01T00:00:00Z